{"paper_id":"a856e23a-d993-4c83-a62a-8ceba4b0d33c","body_text":"Abstract\nBackground\nEndometriosis has many hypothesized etiologies. Known risk factors include genetic predisposition, uterine outflow abnormalities, and iatrogenic causes. Of increasing concern is prenatal environmental exposures. However, the findings of studies investigating the relationships between prenatal environmental exposures and the development of endometriosis have not always been conclusive, and therefore, the relationships are debatable.\nMethods\nThis review presents a summary and analysis of the current studies that investigated the effects of prenatal environmental exposures on the development of endometriosis in female offspring.\nResults\nPrenatal exposureto estrogenic substances (such as ethinyl estradiol and diethylstilbestrol) and environmental toxins (such as 2,3,7,8-tetrachlorodibenzo-p-dioxin, polychlorinated biphenyls, and bisphenol A) may increase the incidence of endometriosis in female offspring. However, exposure to cigarette smoke may protect againstthe development of endometriosis in female offspring mainly because of its antiestrogenic effects.\nConclusion\nCertain prenatal environmental exposures might result in the development of endometriosis in female offspring. In addition to known environmental exposures that predispose the development of endometriosis in adulthood, such as dioxin and radiation exposure (animal modeis), prenatal exposures are of increasing concern.\nSimilar content being viewed by others\nReferences\nKnapp VJ. How old is endometriosis? Late 17th- and 18th-century European descriptions of the disease. Fertil Steril. 1999;72(1):10–14.\nBenagiano G, Brosens I. History of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):449–463.\nSignorile PG, Baldi F, Bussani R, D’Armiento M, De Falco M, Baldi A. Ectopic endometrium in human foetuses is a common event and sustains the theory of mullerianosis in the pathogenesis of endometriosis, a disease that predisposes to Cancer. J Exp Clin Cancer Res. 2009;28:49.\nGiudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789–1799.\nMehedintu C, Plotogea MN, Ionescu S, Antonovici M. Endometriosis still a challenge. J Med Life. 2014;7(3):349–357.\nAbbas S, Ihle P, Köster I, Schubert I. Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related Symptoms:findings from a statutory health insurance-based cohort in Germany. Eur J Obstet Gynecol Reprod Biol. 2012;160(1):79–83.\nHudelist G, Keckstein J, Wright JT. The migrating adenomyoma:past views on the etiology of adenomyosis and endometriosis. Fertil Steril. 2009;92(5):1536–1543.\nKlattig J, Englert C. The Mullerian duct:recent insights into its development and regression. Sex Dev. 2007;1(5):271–278.\nBouquet de Joliniere J, Ayoubi JM, Lesec G, et al. Identification of displaced endometrial glands and embryonic duct remnants in female fetal reproductive tract:possible pathogenetic role in endometriotic and pelvic neoplastic processes. Front Physiol. 2012;3:444.\nHufnagel D, Li F, Cosar E, Krikun G, Taylor HS. The role of stem cells in the etiology and pathophysiology of endometriosis. Semin Reprod Med. 2015;33(5):333–340.\nCramer DW, Missmer SA. The epidemiology of endometriosis. Ann N Y Acad Sci. 2002;955:11–22; discussion 34-36, 396-406.\nBück Louis GM, Hediger ML, Pefia JB. Intrauterine exposures and risk of endometriosis. Hum Reprod. 2007;22(12):3232–3236.\nCummings AM, Hedge JM, Birnbaum LS. Effect of prenatal exposure to TCDD on the promotion of endometriotic lesion growth by TCDD in adult female rats and mice. Toxicol Sci. 1999;52(1):45–49.\nPorpora MG, Medda E, Abballe A, et al. Endometriosis and organochlorinated environmental pollutants:a case-control study on Italian women of reproductive age. Environ Health Perspect. 2009;117(7):1070–1075.\nCalafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect. 2008;116(1):39–44.\nAldad TS, Rahmani N, Leranth C, Taylor HS. Bisphenol-A exposure alters endometrial progesterone receptor expression in the nonhuman primate. Fertil Steril. 2011;96(1):175–179.\nBarker DJ. The fetal and infant origins of adult disease. BMJ. 1990;301(6761):1111.\nSignorile PG, Baldi F, Bussani R, et al. Embryologic origin of endometriosis:analysis of 101 human female fetuses. J Cell Phy-siol. 2012;227(4):1653–1656.\nHaies CN. Fetal and infant origins of adult disease. J Clin Pathol. 1997;50(5):359.\nMoen MH. Why do women develop endometriosis and why is it diagnosed? Hum Reprod. 1995;10(1):8–11.\nSignorile PG, Spugnini EP, Mita L, et al. Prenatal exposure of mice to bisphenol A elicits an endometriosis-like phenotype in female offspring. Gen Comp Endocrinol. 2010;168(3):318–325.\nFraunhoffer NA, Meilerman Abuelafia A, Stella I, Galliano S, Barrios M, Vitullo AD. Identification of germ cell-specific VASA and IFITM3 proteins in human ovarian endometriosis. J Ovarian Res. 2015;8:66.\nFettback PB, Pereira RM, Rocha AM, et al. Expression of stem cell-related genes in the endometrium and endometriotic lesions:apilot study. Gynecol Endocrinol. 2015:1–5.\nKhan KN, Fujishita A, Kitajima M, Hiraki K, Nakashima M, Masuzaki H. Occult microscopic endometriosis:undetectable by laparoscopy in normal Peritoneum. Hum Reprod. 2014; 29(3):462–472.\nHuhtinen K, Saloniemi-Heinonen T, Keski-Rahkonen P, et al. Intratissue Steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions. J Clin Endocrinol Metab. 2014;99(11):e2188–e2197.\nHatch EE, Herbst AL, Hoover RN, et al. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States). Cancer Causes Control. 2001;12(9):837–845.\nKirigaya A, Hayashi S, Iguchi T, Sato T. Developmental effects of ethinylestradiol on reproductive organs of female mice. In Vivo. 2006;20(6b):867–873.\nNewbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol:implications for other environmental estrogens. Environ Health Perspect. 1995;103(suppl 7):83–87.\nKoike E, Yasuda Y, Shiota M, et al. Exposure to ethinyl estradiol prenatally and/or after sexual maturity induces endometriotic and precancerous lesions in uteri and ovaries of mice. Congenit Anom (Kyoto). 2013;53(1):9–17.\nGolden RJ, Noller KL, Titus-Ernstoff L, et al. Environmental endocrine modulators and human health:an assessment of the biological evidence. CritRev Toxicol. 1998;28(2):109–227.\nFerguson JH. Effect of stilbestrol on pregnancy compared to the effect of a placebo. Am J Obstet Gynecol. 1953;65(3):592–601.\nDieckmann WJ, Davis ME, Rynkiewicz LM, Pottinger RE. Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol. 1953;66(5):1062–1081.\nThe use of hormones in the management of pregnancy in diabetics. Lancet. 1955;269(6895):833–836.\nHoover RN, Hyer M, Pfeiffer RM, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med. 2011;365(14):1304–1314.\nHerbst AL, Ulfelder H, Poskanzer DC, Longo LD. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971. Am J Obstet Gynecol. 1999;181(6):1574–1575.\nHilakivi-Clarke L. Maternal exposure to diethylstilbestrol during pregnancy and increased breast Cancer risk in daughters. Breast Cancer Res. 2014;16(2):208.\nHaney AF, Hammond MG. Hammond, Infertility in women exposed to diethylstilbestrol in utero. J Reprod Med. 1983;28(12):851–856.\nMissmer SA, Hankinson SE, Spiegelman D, Barbieri RL, Michels KB, Hunter DJ. In utero exposures and the incidence of endometriosis. Fertil Steril. 2004;82(6):1501–1508.\nBenagiano G, Brosens I. In utero exposure and endometriosis. J Matern Fetal Neonatal Med. 2014;27(3):303–308.\nWolff EF, Sun L, Hediger ML, et al. In utero exposures and endometriosis:the Endometriosis, Natural History, Disease, Out-come (ENDO) Study. Fertil Steril. 2013;99(3):790–795.\nRen X, Wu X, Hillier SG, et al. Local estrogen metabolism in epithelial ovarian Cancer suggests novel targets for therapy. J Steroid Biochem Mol Biol. 2015;150:54–63.\nNoble LS, Takayama K, Zeitoun KM, et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab. 1997;82(2):600–606.\nDeMayo FJ, Zhao B, Takamoto N, Tsai SY. Mechanisms of action of estrogen and progesterone. Ann N Y Acad Sci. 2002;955:48–59; discussion 86-88, 396-406.\nSumitani H, Shozu M, Segawa T, et al. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Endocrinology. 2000;141(10):3852–3861.\nBulun SE, Yang S, Fang Z, et al. Role of aromatase in endometrial disease. J Steroid Biochem Mol Biol. 2001;79(1-5):19–25.\nBrune RM, Bard JB, Dubreuil C, et al. A three-dimensional model of the mouse at embryonic day 9. Dev Biol. 1999;216(2):457–468.\nShao R, Cao S, Wang X, Feng Y, Billig H. The elusive and controversial roles of estrogen and progesterone reeeptors in human endometriosis. Am J Transl Res. 2014;6(2):104–113.\nBurns KA, Korach KS. Estrogen reeeptors and human disease:an update. Arch Toxicol. 2012;86(10):1491–1504.\nHapangama DK, Kamal AM, Bulmer JN. Estrogen receptor beta:the guardian of the endometrium. Hum Reprod Update. 2015;21(2):174–193.\nRiley CF, Moen MH, Videm V. Inflammatory markers in endometriosis:reduced peritoneal neutrophil response in minimal endometriosis. Acta Obstet Gynecol Scand. 2007;86(7):877–881.\nWang YQ, Yin LR, Guo RM, Sheng W. Role of epidermal growth factor signaling System in the pathogenesis of endometriosis under estrogen deprivation conditions. Zhonghua Fu Chan Ke Za Zhi. 2013;48(6):447–452.\nSchoeters G, Den Hond E, Dhooge W, van Larebeke N, Leijs M. Endoerine disruptors and abnormalities of pubertal development. Basic Clin Pharmacol Toxicol. 2008;102(2):168–175.\nHotchkiss AK, Rider CV, Blystone CR, et al. Fifteen years after “Wingspread”-environmental endocrine disrupters and human and wildlife health:where we are today and where we need to go. Toxicol Sci. 2008;105(2):235–259.\nJacobson-Dickman E, Lee MM. The influence of endocrine disruptors on pubertal timing. Curr Opin Endocrinol Diabetes Obes. 2009;16(1):25–30.\nGray LE Jr, Ostby JS. In utero 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters reproduetive morphology and funetion in female rat offspring. Toxicol Appl Pharmacol. 1995; 133(2):285–294.\nCouture LA, Harris MW, Birnbaum LS. Characterization of the peak period of sensitivity for the induetion of hydrone-phrosis in C57BL/6N mice following exposure to 2,3,7, 8-tet-rachlorodibenzo-p-dioxin. Fundam Appl Toxicol. 1990;15(1):142–150.\nBruner-Tran KL, Ding T, Osteen KG. Dioxin and endometrial progesterone resistance. Semin Reprod Med. 2010;28(1):59–68.\nGuo SW. The link between exposure to dioxin and endometriosis:a critical reappraisal of primate data. Gynecol Obstet luvest. 2004;57(3):157–173.\nGuo SW, Simsa P, Kyama CM, et al. Reassessing the evidence for the link between dioxin and endometriosis:from molecular biol-ogy to clinical epidemiology. Mol Hum Reprod. 2009;15(10):609–624.\nOkino ST, Whitlock JP Jr. The aromatic hydrocarbon reeeptor, transcription, and endocrine aspects of dioxin action. Vitam Horm. 2000;59:241–264.\nSherr DH. Another important biological funetion for the aryl hydrocarbon reeeptor. Arterioscler Thromb Vase Biol. 2011; 31(6):1247–1248.\nSherr DH, Monti S. The role of the aryl hydrocarbon reeeptor in normal and malignant B cell development. Semin Immunopathol. 2013;35(6):705–716.\nMimura J, Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta. 2003;1619(3):263–268.\nOsteen KG, Bruner-Tran KL, Eisenberg E. Reduced progesterone action during endometrial maturation:a potential risk factor for the development of endometriosis. Fertil Steril. 2005;83(3):529–537.\nNayyar T, Bruner-Tran KL, Piestrzeniewicz-Ulanska D, Osteen KG. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Reprod Toxicol. 2007;23(3):326–336.\nBruner-Tran KL, Osteen KG. Dioxinlike PCBs and endometriosis. Syst Biol Reprod Med. 2010;56(2):132–146.\nQuaranta MG, Porpora MG, Mattioli B, et al. Impaired NK-cell-mediated cytotoxic activity and cytokine production in patients with endometriosis:a possible role for PCBs and DDE. Life Sci. 2006;79(5):491–498.\nMaffini MV, Rubin BS, Sonnenschein C, Soto AM. Endocrine disruptors and reproduetive health:the case of bisphenol-A. Mol Cell Endocrinol. 2006;254-255:179–186.\nUpson K, Sathyanarayana S, De Roos AJ, Koch HM, Scholes D, Holt VL. A population-based case-control study of urinary bisphenol A concentrations and risk of endometriosis. Hum Reprod. 2014;29(11):2457–2464.\nAgarwal DK, Eustis S, Lamb JC IV, Reel JR, Kluwe WM. Effects of di(2-ethylhexyl) phthalate on the gonadal pathophysiology, sperm morphology, and reproduetive Performance of male rats. Environ Health Perspect. 1986;65:343–350.\nHonma S, Suzuki A, Buchanan DL, Katsu Y, Watanabe H, Iguchi T. Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol. 2002;16(2):117–122.\nDiamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals:an Endocrine Society scientific Statement. Endocr Rev. 2009;30(4):293–342.\nBosquiazzo VL, Vigezzi L, Munoz-de-Toro M, Luque EH. Perinatal exposure to diethylstilbestrol alters the functional dif-ferentiation of the adult rat Uterus. J Steroid Biochem Mol Biol. 2013;138:1–9.\nQuignot N, Arnaud M, Robidel F, et al. Characterization of endocrine-disrupting chemicals based on hormonal balance dis-ruption in male and female adult rats. Reprod Toxicol. 2012; 33(3):339–352.\nPrins GS. Estrogen imprinting: when your epigenetic memories come back to haunt you. Endocrinology. 2008;149(12):5919–5921.\nZanatta A, Pereira RM, Rocha AM, et al. The relationship among HOXA10, estrogen reeeptor alpha, progesterone reeeptor, and progesterone reeeptor B proteins in rectosigmoid endometriosis:a tissue microarray study. Reprod Sci. 2015;22(1):31–37.\nMcGinnis W, Krumlauf R. Homeobox genes and axial patterning. Cell. 1992;68(2):283–302.\nZanatta A, Rocha AM, Carvalho FM, et al. The role of the HoxalO/HOXAlO gene in the etiology of endometriosis and its related infertility:a review. J Assist Reprod Genet. 2010;27(12):701–710.\nHammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. Smoking in pregnancy revisited:findings from a large population-based study. Am J Obstet Gynecol. 2005; 192(6):1856–1862; discussion 1862-1863.\nHarrod CS, Reynolds RM, Chasan-Taber L, et al. Quantity and timing of maternal prenatal smoking on neonatal body compositum:the Healthy Start study. J Pediatr. 2014;165(4):707–712.\nKale PL, Fonseca SC, da Silva KS, et al. Smoking prevalence, reduction, and cessation during pregnancy and associated factors:a cross-sectional study in public maternities, Rio de Janeiro, Brazil. BMC Public Health. 2015;15:406.\nEngland LJ, Levine RJ, Qian C, et al. Smoking before pregnancy and risk of gestational hypertension and preeclampsia. Am J Obstet Gynecol. 2002;186(5):1035–1040.\nSomigliana E, Vigano P, Abbiati A, et al. Perinatal environment and endometriosis. Gynecol Obstet Invest. 2011;72(2):135–140.\nNicklas BJ, Tomoyasu N, Muir J, Goldberg AP. Effects of cigarette smoking and its cessation on body weight and plasma leptin levels. Metabolism. 1999;48(6):804–808.\nLi P, Beck WD, Callahan PM, Terry AV Jr, Bartlett MG. Pharmacokinetics of cotinine in rats: a potential therapeutic agent for disorders of cognitive fimction. Pharmacol Rep. 2015;67(3):494–500.\nIvey R, Desai M, Green K, Sinha-Hikim I, Friedman TC, Sinha-Hikim AP. Additive effects of nicotine and high-fat diet on hepa-tocellular apoptosis in mice:involvement of caspase 2 and inducible nitric oxide synthasemediated intrinsic pathway signaling. Horm Metab Res. 2014;46(8):568–573.\nRocha AL, Reis FM, Taylor RN. Angiogenesis and endometriosis. Obstet Gynecol Int. 2013;2013:859619.\nGrizzell JA, Mullins M, Iarkov A, Rohani A, Charry LC, Echeverria V. Cotinine reduces depressive-like behavior and hippo-campal vascular endothelial growth factor downregulation after forced swim stress in mice. Behav Neurosci. 2014;128(6):713–721.\nCooke JP, Bitterman H. Nicotine and angiogenesis:a new paradigm for tobaccorelated diseases. Ann Med. 2004;36(1):33–40.\nXanthoulea S, Deliaert A, Romano A, Rensen SS, Buurman WA, van der Hulst RR. Nicotine effect on inflammatory and growth factor responses in murine cutaneous wound healing. Int Immunopharmacol. 2013;17(4):1155–1164.\nWu Y, Wang LP, Pan JQ. Nicotinic acetylcholine receptor agonists may be a novel therapy for endometriosis. Med Hypotheses. 2011;77(5):745–747.\nde Jonge WJ, van der Zanden EP, The FO, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005;6(8):844–851.\nTracey KJ. The inflammatory reflex. Nature. 2002;420(6917):853–859.\nKobayashi H, Imanaka S, Nakamura H, Tsuji A. Understanding the role of epigenomic, genomic and genetic alterations in the development of endometriosis (review). Mol Med Rep. 2014; 9(5):1483–1505.\nAuthor information\nAuthors and Affiliations\nCorresponding authors\nRights and permissions\nAbout this article\nCite this article\nWei, M., Chen, X., Zhao, Y. et al. Effects of Prenatal Environmental Exposures on the Development of Endometriosis in Female Offspring. Reprod. Sci. 23, 1129–1138 (2016). https://doi.org/10.1177/1933719116630418\nPublished:\nIssue date:\nDOI: https://doi.org/10.1177/1933719116630418","source_license":"CC0","license_restricted":false}